Teladoc expands virtual primary care pilot to plans nationwide
The vendor hopes Primary360 will serve as an access point to the healthcare system while also enticing patients to its other services.
Pfizer officially seeks FDA clearance for coronavirus vaccine in children
The companies’ application starts a pressure-packed FDA review that could open up COVID-19 shots for tens of million Americans between the ages of 5 and 11.
Feds OK health plan discounts for coronavirus vaccination
Such rewards must meet certain requirements, however, including a rule that they not exceed 30% of the cost of employee-only coverage.
Hospital M&A in 2021 characterized by fewer but much larger deals
Hospitals are increasing looking outside traditional care delivery methods threatened by COVID-19 to diversify business models by pursuing stakes in home health, virtual care and post-acute services.
How Morgan Health hopes to finally move the needle on employer health costs: 5 insights from a chat with the venture’s CEO
Morgan Health learned a lot from Haven, but is a different beast with a better knowledge of the buy-in needed to disrupt the health benefits space, CEO Dan Mendelson told Healthcare Dive.
FDA’s real-world evidence push hampered by data challenges, ‘million-dollar question’
While the agency wants to tap information like electronic health records and wearables to make pre- and postmarket decisions, these sources do not have the same quality controls as clinical trials.
Labor shortages will strain hospital budgets through 2022, Moody’s says
The pressure on health system profitability comes as lucrative non-emergency procedures are on hold in some areas to handle incoming COVID-19 inpatients, according to the report.
HCA sells another Georgia hospital, with $637M price tag
The latest deal means the system will no longer have a footprint in the northwest part of the state after completing a divestiture plan of offloading hospitals surrounding the Atlanta area.
J&J asks FDA to clear booster dose of its coronavirus vaccine
The agency is holding an advisory committee meeting on Oct. 15 to discuss a second dose of J&J’s shot, as well as boosting with different vaccines.
Collins to step down as NIH head in transition for research agency
After 12 years in the top job, the veteran director says a new scientist should assume leadership of the world’s largest biomedical research institution.